RE:RE:Early HER2-Targeted Therapies in Breast Cancer offers hopeClarification : digital signal processing = digital spatial profiling (Nanostring's nCounter® system) which provides a better characterization and understanding of tumor heterogeneity and the tumor micro-environment (TME), enabling the improvement of patient therapy and the identification of potential biomarker signatures.